ATE279198T1 - Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung - Google Patents

Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Info

Publication number
ATE279198T1
ATE279198T1 AT98942166T AT98942166T ATE279198T1 AT E279198 T1 ATE279198 T1 AT E279198T1 AT 98942166 T AT98942166 T AT 98942166T AT 98942166 T AT98942166 T AT 98942166T AT E279198 T1 ATE279198 T1 AT E279198T1
Authority
AT
Austria
Prior art keywords
endometrum
progestagens
oral contraception
spareing
atrophizing
Prior art date
Application number
AT98942166T
Other languages
German (de)
English (en)
Inventor
Michael Kafrissen
Haya Taitel
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE279198T1 publication Critical patent/ATE279198T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT98942166T 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung ATE279198T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (1)

Publication Number Publication Date
ATE279198T1 true ATE279198T1 (de) 2004-10-15

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942166T ATE279198T1 (de) 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Country Status (9)

Country Link
EP (1) EP1007052B1 (enExample)
JP (1) JP2001513566A (enExample)
AT (1) ATE279198T1 (enExample)
AU (1) AU9028098A (enExample)
DE (1) DE69827017T2 (enExample)
DK (1) DK1007052T3 (enExample)
ES (1) ES2230711T3 (enExample)
PT (1) PT1007052E (enExample)
WO (1) WO1999009993A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
CA2524474A1 (en) * 2003-05-02 2004-11-18 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
JP2007534622A (ja) * 2003-07-16 2007-11-29 デュラメド ファーマシューティカルズ インコーポレーティッド 連続的エストロゲン投与での避妊薬療法を利用するホルモン処置の方法
JP2007507534A (ja) * 2003-10-01 2007-03-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 持続的三相避妊方法
EP1535618A1 (en) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
FI101601B1 (fi) * 1987-09-24 1998-07-31 Jencap Research Ltd Ehkäisyvalmiste sekä estrogeenin ja progestiinin käyttö ehkäisyvalmisteen valmistusmenetelmässä
DE4104385C1 (enExample) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
DK1007052T3 (da) 2005-01-31
JP2001513566A (ja) 2001-09-04
ES2230711T3 (es) 2005-05-01
DE69827017D1 (de) 2004-11-18
EP1007052A1 (en) 2000-06-14
AU9028098A (en) 1999-03-16
WO1999009993A1 (en) 1999-03-04
PT1007052E (pt) 2005-01-31
DE69827017T2 (de) 2006-03-09
EP1007052B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
GT199800126A (es) Terapia de combinacion.
NO964966L (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
CY2009015I2 (el) Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
ES2132645T3 (es) Uso en una composicion farmaceutica.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
KR970704430A (ko) 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
ATE162945T1 (de) Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel
ATE304359T1 (de) Anti-östrogen- und progestin-enthaltende orale kontrazeptiva
TR199700930T2 (xx) Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit.
GB2199747B (en) Fluticasone propionate compositions and their use in bowel diseases.
EP0569862A3 (en) Self-adhesive medical sheet and medical preparation.
NO986104D0 (no) Progesteron-anti-progesteron regimer
DE69932510D1 (de) Vaskularisierungsinhibitoren
NO20004419L (no) Ny anvendelse
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
ITMI992107A0 (it) Uso del baclofen nel trattamento dell'astinenza da etanolo
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
HUP0203721A2 (hu) Új hormonkészítmény és alkalmazása
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
AU1518902A (en) Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
ES2079687T3 (es) Composicion topica.
ES2152315T3 (es) Xamoneline tartrato.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007052

Country of ref document: EP